Pfizer drug extends life for people with rare form of lung cancer
A Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival outcomes for people in the advanced stages of a rare form of the disease, according to trial results published Friday.
May 31, 2024
0
0